CD44细胞
转移
癌症研究
体内
阿霉素
三阴性乳腺癌
化学
透明质酸
药物输送
胶束
肿瘤微环境
靶向给药
体外
药理学
乳腺癌
癌症
医学
生物
化疗
内科学
生物化学
肿瘤细胞
水溶液
生物技术
有机化学
物理化学
解剖
作者
Yiliang Yang,Yang Long,Yashi Wang,Kebai Ren,Man Li,Zhirong Zhang,Bing Xiang,Qin He
标识
DOI:10.1016/j.ijpharm.2020.119085
摘要
Tumor growth and metastasis are multistep processes regulated by multiple signaling pathways. The successful treatment of cancer largely depends on the ability to inhibit metastatic process. Multiphase inhibition of metastasis is a promising approach. Here, we described a targeting delivery system which was constructed by mixing hyaluronic acid-d-α-tocopheryl succinate (HA-TOS, HT) and low molecular weight heparin-TOS (LMWH-TOS, LT) to form a stable hybrid micelle (HT-LT), encapsulating chemotherapeutic drug doxorubicin (DOX). The prepared HT-LT NPs was about 125 nm in diameter with high drug encapsulation rate and continuous drug release behavior. We confirmed that HT-LT NPs exhibited an effective targeting ability both in vitro and in vivo using a 4T1 model that was attributed to HA binding to CD44 receptors. In addition, HT-LT NPs acted on different phases of the invasion-metastasis cascade and inhibited tumor cell migration and invasion, thus inhibiting tumor metastasis. This combinatorial strategy provided an alternative approach for triple negative breast cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI